Skip to main content

Table 2 Baseline characteristics

From: Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia

Patient characteristic All patients (n = 111)
Male, n (%) 71 (64%)
Age at baseline ECG (years) 43 (30–56)
Systolic blood pressure (mmHg) 120 ± 19
Diastolic blood pressure (mmHg) 76 ± 9
Heart rate (bpm) 65 (57–74)
Body mass index (kg/m2) 24.3 ± 3.2
Medication  
Amiodarone, n (%) 17 (15%)
Beta-blocker, n (%) 47 (42%)
Sotalol, n (%) 13 (12%)
12-lead surface ECG  
Epsilon waves in V1, V2, or V3 21 (19%)
Minor ECG depolarization criteria (2010 TFC) 25 (23%)
Terminal activation duration (ms) 52 (43–64)
Major ECG repolarization criteria (2010 TFC) 37 (33%)
Minor ECG repolarization criteria (2010 TFC) 21 (19%)
TWI in inferior leads 38 (34%)
TWI in V4, V5, or V6 43 (39%)
Number of leads with TWI 4.5 ± 2.5
Number of precordial leads with TWI 2.6 ± 1.9
QRS duration (ms) 111 (100–116)
Corrected QT duration (ms) 444 (426–480)
Transthoracic echocardiography  
Patients with RV regional wall motion abnormalities 85 (77%)
1 RV region involved 25 (23%)
≥2 RV regions involved 56 (50%)
Patients with LV involvement 15 (14%)
  1. Abbreviations: ARVC/D Arrhythmogenic right ventricular cardiomyopathy/dysplasia, LV left ventricular, RV right ventricular, TFC 2010 Revised ARVC/D Task Force Criteria, TWI T wave inversions.
  2. Values are means ± standard deviation, medians with interquartile ranges and numbers (percentages).